|
WASHINGTON
(H24N) Adult women who suffer from acne may find some
relief taking a drug called spironolactone if their acne is caused
by hormonal imbalances, according to a new report.
When
used in high doses, spironolactone often leads to breast tenderness,
fatigue, irregular menstrual cycles, dizziness and headache. However,
when the dose is lowered, spironolactone has been found effective
in clearing up or at least reducing acne in adult women.
The
results of the study are published in the September issue of the
Journal of the American Academy of Dermatology.
"Despite
advances in acne therapy in recent years, treatment failures are
common, especially in adult women," wrote the study’s author,
James Shaw, M.D., with the University of Chicago. "Spironolactone
is successful in treating adult women with acne. … It can be used
in low doses as a single drug or as an adjunct to standard acne
therapies in women."
Spironolactone
works by blocking androgen receptors. It is a diuretic that is sometimes
used to treat patients with heart failure. The study found that
when used alone or with other treatments, the drug was a highly
effective acne treatment for women who had little or no success
with other treatments such as oral contraceptives, oral antibiotics
and isotretinoin.
Eighty-five
women, between the ages of 18 and 52, took part in the study. Their
acne had been diagnosed as hormonal because it began in adulthood,
tended to get exacerbated around the time of their menstrual periods
or was associated with ovarian cysts.
The
women took 50 to 100 milligrams of spironolactone a day, instead
of the usual 150 to 200 milligrams daily dosage. Thirty-three percent
saw their acne clear up completely, 33 percent had marked improvement,
27.4 percent had partial improvement, and 7 percent saw no improvement.
Shaw
said that the drug was well tolerated, with almost 60 percent of
the women reporting no side effects, and only one in five reporting
menstrual irregularity. Nineteen of the women had slightly lowered
blood pressure, and only 5 percent of the women reported breast
tenderness.
|